Return to Pakistan of pipenzolate plus phenobarbitone.
Tahir
K I
KI
D004345:Drug Industry; D006801:Humans; D007231:Infant, Newborn; D007880:Legislation, Drug; D010154:Pakistan; D010276:Parasympatholytics / Q000009:adverse effects / Q000600:supply & distribution*; D010634:Phenobarbital / Q000009:adverse effects / Q000600:supply & distribution*; D010880:Piperidines / Q000009:adverse effects / Q000600:supply & distribution*
D010276:Parasympatholytics; D010880:Piperidines; C004377:pipenzolate; D010634:Phenobarbital